skip to main content
Idioma:
Refinado por: Lista de Todas as Versões British Journal Of Cancer remover Lista de Todas as Versões Middle Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53
Material Type:
Artigo 		Adicionar ao Meu Espaço

HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53

Meulendijks, D ; Tomasoa, N B ; Dewit, L ; Smits, P H M ; Bakker, R ; van Velthuysen, M-L F ; Rosenberg, E H ; Beijnen, J H ; Schellens, J H M ; Cats, A

British journal of cancer, 2015-04, Vol.112 (8), p.1358-1366 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo

Schwab, C L ; Bellone, S ; English, D P ; Roque, D M ; Lopez, S ; Cocco, E ; Nicoletti, R ; Bortolomai, I ; Bonazzoli, E ; Ratner, E ; Silasi, D-A ; Azodi, M ; Schwartz, P E ; Rutherford, T J ; Santin, A D

British journal of cancer, 2014-10, Vol.111 (9), p.1750-1756 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer

BURCOMBE, R. J ; MAKRIS, A ; RICHMAN, P. I ; DALEY, F. M ; NOBLE, S ; PITTAM, M ; WRIGHT, D ; ALLEN, S. A ; DOVE, J ; WILSON, G. D

British journal of cancer, 2005-01, Vol.92 (1), p.147-155 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling
A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase II study of sequential neoadjuvant gemcitabine plus doxorubicin followed by gemcitabine plus cisplatin in patients with operable breast cancer: prediction of response using molecular profiling

JULKA, P. K ; CHACKO, R. T ; DHINDSA, N ; MILLER, I. D ; MA, D ; LIN, B ; AWASTHY, B ; PEROUOU, C. M ; NAG, S ; PARSHAD, R ; NAIR, A ; OH, D. S ; HU, Z ; KOPPIKER, C. B ; NAIR, S ; DAWAR, R

British journal of cancer, 2008-04, Vol.98 (8), p.1327-1335 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection

Cacheux, Wulfran ; Rouleau, Etienne ; Briaux, Adrien ; Tsantoulis, Petros ; Mariani, Pascale ; Richard-Molard, Marion ; Buecher, Bruno ; Dangles-Marie, Virginie ; Richon, Sophie ; Lazartigues, Julien ; Jeannot, Emmanuelle ; Farkhondeh, Fereshteh ; Sastre-Garau, Xavier ; de La Rochefordière, Anne ; Labib, Alain ; Falcou, Marie-Christine ; Stevens, Denise ; Roth, Arnaud ; Roman-Roman, Sergio ; Mitry, Emmanuel ; Bièche, Ivan ; Lièvre, Astrid

British journal of cancer, 2016-06, Vol.114 (12), p.1387-1394 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients
Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients

Myklebust, M P ; Fluge, Ø ; Immervoll, H ; Skarstein, A ; Balteskard, L ; Bruland, O ; Dahl, O

British journal of cancer, 2012-02, Vol.106 (4), p.756-762 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Detection of human parvovirus B19 in papillary thyroid carcinoma
Detection of human parvovirus B19 in papillary thyroid carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Detection of human parvovirus B19 in papillary thyroid carcinoma

WANG, J. H ; ZHANG, W. P ; CHEN, L. W ; HUANG, G. S ; LIU, H. X ; WANG, D ; LI, Y. F ; WANG, W. Q ; WANG, L ; HE, F. R ; WANG, Z ; YAN, Q. G

British journal of cancer, 2008-02, Vol.98 (3), p.611-618 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Changes in allelic imbalances in locally advanced breast cancers after chemotherapy
Changes in allelic imbalances in locally advanced breast cancers after chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Changes in allelic imbalances in locally advanced breast cancers after chemotherapy

VARNA, M ; SOLIMAN, H ; JANIN, A ; DE TH, H ; BERTHEAU, P ; FEUGEAS, J.-P ; TURPIN, E ; CHAPELIN, D ; LEGRES, L ; PLASSA, L.-F ; DE ROQUANCOURT, A ; ESPIE, M ; MISSET, J.-L

British journal of cancer, 2007-10, Vol.97 (8), p.1157-1164 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Bone marrow micrometastases in early breast cancer-30-year outcome
Bone marrow micrometastases in early breast cancer-30-year outcome
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bone marrow micrometastases in early breast cancer-30-year outcome

Mansi, J ; Morden, J ; Bliss, J M ; Neville, M ; Coombes, R C

British journal of cancer, 2016-02, Vol.114 (3), p.243-247 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials
Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials

AL-BATRAN, S.-E ; GÜNTNER, M ; PAUTIGK, C ; SCHOLZ, M ; CHEN, R ; BEISS, B ; STOPATSCHINSKAJA, S ; LERBS, W ; HARBECK, N ; JÄGER, E

British journal of cancer, 2010-11, Vol.103 (10), p.1518-1523 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.